Topics in Drug Testing from Quest Diagnostics
Health & Fitness
Today’s podcast will cover dangerous drug combinations and the role of clinical drug monitoring. Some of the key information that will be shared includes:
This episode features Quest Diagnostics Senior Medical Advisor Dr Jeff Gudin and Medical Science Liaison Dr Jack Kain.
----more----
You may download the PDF version of this presentation here>>
To learn more, please visit QuestDrugMonitoring.com for information on our Drug Monitoring Test Directory and offerings, as well as educational resources and insights from our team of toxicology experts. At Quest Diagnostics, we are committed to providing you results and insights to support your clinical decisions.
Medication adherence testing
Limitations of point-of-care testing
Phosphatidylethanol (PEth) blood test - Now available from Quest Diagnostics
The CDC Clinical Practice Guideline for Prescribing Opioids for Pain
Ketamine: a re-emergence in medicine and misuse?
Windows of Detection
Contributing Factors to the Skyrocketing Drug Misuse Epidemic in the US
Fentanyl: A substance of great concern
Presumptive vs definitive drug testing: what you need to know
Special Episode: Trends in drug testing resulting from the COVID-19 pandemic
Pharmacogenomics in mental health and addiction
Implementing a Drug Monitoring Protocol in your practice
Alternative Specimen Collection Options
The epidemic within the pandemic
Drug testing for stimulants
Drug Monitoring in Behavioral Health and during times of crisis
Drug Misuse in America
Kratom: Identifying ”a drug of concern”
Why and when to use oral fluid testing
Create your
podcast in
minutes
It is Free
The Relaxback UK Show
Your Sleep Guru Podcast
Good Nurse Bad Nurse
Nothing much happens: bedtime stories to help you sleep
این نقطه